US District Court rules against Watson in generic Fentora patent suit - 研发专利新闻

添加时间:2011-04-07 原文发表:2011-03-25 人气:2

Watson Pharmaceuticals, Inc. (NYSE: WPI), today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora (fentanyl buccal tablets C-II) infringes United States Patent...

查看所有的文章内容需要 VIP会员权限查看

点这里复制本页地址发送给您QQ/MSN上的好友

• USPTO issues Notice of Allowance to Alph

• VARI, Gentel Biosciences receive U.S. Pa

• Colorcon announces specific details on i

• ACT to be awarded broad patent protectio

• NephRx receives new U.S. patent for NX00

• USPTO grants patent to ULURU's Altrazeal

• NephRx receives new U.S. patent for NX00

• PRWP receives two new patents for Galect

• POZEN files motion for Treximet patent l

• BDSI's BEMA drug delivery technology rec

• U.S. District Court rules in favor of Wa

• Biotectix acquires Chameleon BioSurfaces

• USPTO issues Notice of Allowance to Modu

• USPTO issues patent to Somaxon's Silenor

• USPTO grants composition-of-matter paten

• USPTO issues patent to Asterand's BioMAP

• Medical industry veteran set to play key

• Cubist enters license agreement with Tev

• Shire files lawsuit against Watson over

• USPTO issues notice of allowance to Mirn

网站首页

行业信息

市场快讯

SFDA新闻精选

调研报告

研发动态

研发专利新闻

新闻公告

您的位置：网站名称 → 研发专利新闻 → 正文